TickerFacts.

Petros Pharmaceuticals, Inc. (PTPI): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.21M
Year ended 2024-12-31
-8.8%
3-year compound annual growth
$4.05M2020-12-31: $4.05M2021-12-31: $1.60M2022-12-31: $2.29M2023-12-31: $1.63M2024-12-31: $1.21M$1.21M
2020-12-31 Cost of Revenue (USD) 2024-12-31
Period endedCost of RevenueChange YoYSource filing
2024-12-31$1.21M-25.7%2025-03-31, From 2024-01-01
2023-12-31$1.63M-28.7%2025-03-31, From 2023-01-01
2022-12-31$2.29M+43.1%2024-04-01, From 2022-01-01
2021-12-31$1.60M-60.5%2023-03-31, From 2021-01-01
2020-12-31$4.05Mn/a2022-03-31, From 2020-01-01